PDCD1LG2 and non-Hodgkin lymphoma: It is inspiring that we found the significantly higher expression of PD-L1 in T-NHL monocytes and PD-L2 (PDCD1LG2) in CD16 + monocytes since it may help predict the PD-1/PD-L1 blockage treatment response in T-NHL.